Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes
Clinical trial NCT06506812 · COMPLETED
Trial details
- NCT number
- NCT06506812
- Sponsor
- Tor Biering-Sørensen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-31
- Primary completion
- 2025-05-31
- Enrollment
- 466320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.